Lauras lab.indd
Mumbai, March 04, 2018: Laurus Labs Ltd said that the USFDA audit has been successfully completed without observations – ZERO 483 for its Unit 2 (formulations unit). The inspection was carried out from Feb 26 2018 to March 1, 2018.
Laurus Labs Ltd has also received its maiden Approval from United States Food and Drug Administration (U. S FDA) for Tenofovir Disoproxil Fumarate Tablets 300mg.
Tenofovir Disoproxil Fumarate Tablets 300mg is therapeutically equivalent to VIREAD Tablets 300mg of Gilead Science Ltd.
Corporate Comm India(CCI Newswire)
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…